XML 76 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2023
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of changes in share capital

Number

  

  

of shares

  

  

Amount

 

Balance at January 1, 2022

 

191,334,392

$

5,628.5

Exercise of stock options

148,295

12.2

Vesting of restricted share units

49,919

6.4

Dividend reinvestment plan

360,085

48.2

Balance at December 31, 2022

191,892,691

$

5,695.3

Balance at January 1, 2023

191,892,691

$

5,695.3

Exercise of stock options

61,000

3.8

Dividend reinvestment plan

221,351

29.1

Balance at December 31, 2023

192,175,042

$

5,728.2

Schedule of dividends paid

  

  

2023

  

  

2022

  

Cash dividends

$

233.0

$

197.6

DRIP dividends

 

29.1

 

48.2

$

262.1

$

245.8

Schedule of options to purchase common shares that have been granted

  

  

    

Weighted

  

average exercise

Number

price

Stock options outstanding, at January 1, 2022

 

822,046

C$

97.88

Granted

 

67,604

 

C$

183.61

Exercised

 

(148,295)

 

C$

82.81

Forfeited

(16,702)

C$

168.43

Stock options outstanding, at December 31, 2022

 

724,653

 

C$

107.34

Stock options outstanding, at January 1, 2023

724,653

C$

107.34

Granted

5,548

 

C$

169.78

Exercised

(61,000)

 

C$

64.50

Stock options outstanding, at December 31, 2023

 

669,201

 

C$

111.76

Exercisable stock options, at December 31, 2022

584,522

C$

90.84

Exercisable stock options, at December 31, 2023

 

570,572

 

C$

100.51

Schedule of fair value of options calculated using Black-Scholes option pricing model and weighted average assumptions utilized

2023

2022

Risk-free interest rate

4.08

%

2.93

%

Expected dividend yield

1.10

%

0.92

%

Expected price volatility of the Company’s common shares

30.9

%

30.0

%

Expected life of the option

 

4 years

4 years

Forfeiture rate

0

%

0

%

Schedule of options to purchase common shares outstanding, exercise prices and weighted average lives to maturity

    

    

    

Weighted

 

Exercise

Options

Options

average life

 

price

outstanding

exercisable

(years)

 

C$40.87

 

28,056

 

28,056

 

0.22

C$58.67

 

20,000

 

20,000

 

1.64

C$59.52

 

27,751

 

27,751

 

0.95

C$65.76

 

51,577

 

51,577

 

1.95

C$75.45

 

117,894

 

117,894

 

2.95

C$88.76

45,082

45,082

4.64

C$94.57

54,221

54,221

4.95

C$100.10

50,470

50,470

3.95

C$129.32

77,408

77,408

5.95

C$164.99

 

4,400

 

 

C$168.43

 

64,996

 

25,998

 

7.95

C$168.72

 

7,968

 

1,594

 

8.64

C$171.33

 

58,594

 

58,594

 

6.95

C$178.01

 

8,030

 

1,606

 

8.38

C$181.57

 

29,470

 

5,894

 

8.38

C$185.70

 

2,299

 

460

 

8.88

C$188.13

 

1,148

 

 

C$194.65

 

19,837

 

3,967

 

8.95

    

669,201

    

570,572

    

4.71

Schedule of number of shares outstanding

  

Performance-

    

Time-based

    

  

based RSUs

    

RSUs

    

Total RSUs

Balance at January 1, 2022

66,794

32,100

98,894

Granted

37,486

15,643

53,129

Settled

(33,229)

(16,690)

(49,919)

Balance at December 31, 2022

71,051

31,053

102,104

Balance at January 1, 2023

71,051

31,053

102,104

Granted

Settled

Balance at December 31, 2023

71,051

31,053

102,104

Schedule of share purchase warrants

  

  

2023

  

  

2022

 

Common shares outstanding

 

192,175,042

191,892,691

Stock options(1)

669,201

724,653

Restricted Share Units(2)

102,104

102,104

192,946,347

192,719,448

DSU plan  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of number of shares outstanding

  

  

2023

  

  

2022

 

Balance at beginning of year

 

110,128

107,635

Granted

11,816

14,703

Settled

(2,515)

(12,210)

Balance at end of year

119,429

110,128